Order Article Reprints

Ferrero J-M, Mahammedi H, Gravis G, Roubaud G, Beuzeboc P, Largillier R, Borchiellini D, Linassier C, Ebran N, Pace-Loscos T, et al. Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer. Pharmaceutics. 2023; 15(2):651. https://doi.org/10.3390/pharmaceutics15020651

Ferrero, Jean-Marc, Hakim Mahammedi, Gwenaelle Gravis, Guilhem Roubaud, Philippe Beuzeboc, Remi Largillier, Delphine Borchiellini, Claude Linassier, Nathalie Ebran, Tanguy Pace-Loscos, and et al. 2023. "Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer" Pharmaceutics 15, no. 2: 651. https://doi.org/10.3390/pharmaceutics15020651

Ferrero, J.-M., Mahammedi, H., Gravis, G., Roubaud, G., Beuzeboc, P., Largillier, R., Borchiellini, D., Linassier, C., Ebran, N., Pace-Loscos, T., Etienne-Grimaldi, M.-C., Schiappa, R., Gal, J., & Milano, G. (2023). Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer. Pharmaceutics, 15(2), 651. https://doi.org/10.3390/pharmaceutics15020651